Mereo BioPharma (MREO) Return on Assets [ROA] (2024 - 2026)
Mereo BioPharma (MREO) posted Return on Assets [ROA] of -74.60% for Q2 2026, up 1.07 percentage points from -75.68% a year earlier and up 7.93 percentage points from the prior quarter.
Powered by 
Analysis
Mereo BioPharma (MREO) Return on Assets [ROA] (2024 - 2026) Analysis & Trends
For FY2025, Mereo BioPharma's Return on Assets [ROA] came in at -68.48%, down 7.94 percentage points from FY2024.
- In prior years, Mereo BioPharma's Return on Assets [ROA] was -60.54% in FY2024 (-19.59 pp) and -40.95% in FY2023.
- Quarterly Return on Assets [ROA] has run from a low of -84.16% in Q4 2025 to a high of -43.03% in Q1 2024 over five years.
- On a year-over-year basis, Return on Assets [ROA] increased in 1 of the last six quarters, with an average year-over-year change of -19.99 percentage points.
- According to Business Quant data, Return on Assets [ROA] for the three prior quarters was -82.54% (Q1 2026), -84.16% (Q4 2025) and -71.53% (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | ROA (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,230.11 Bn | 1,198.70 Bn | 19.71 Bn | 20.64% |
| 2 | Johnson & Johnson | 644.39 Bn | 564.25 Bn | 17.30 Bn | 8.08% |
| 3 | AbbVie | 503.52 Bn | 476.68 Bn | 12.70 Bn | 4.65% |
| 4 | Merck | 363.29 Bn | 317.72 Bn | 12.21 Bn | 2.45% |
| 5 | Novartis Ag | 298.23 Bn | 262.62 Bn | 11.24 Bn | 10.60% |
| 6 | Astrazeneca | 267.53 Bn | 241.29 Bn | 12.86 Bn | 9.10% |
| 7 | Amgen | 241.80 Bn | 197.20 Bn | 7.24 Bn | 9.29% |
| 8 | Gilead Sciences | 195.07 Bn | 169.19 Bn | 6.22 Bn | -6.13% |
| 9 | Pfizer | 173.33 Bn | 120.28 Bn | 10.94 Bn | 2.14% |
| 10 | Mereo BioPharma | 46.31 Mn | -103.60 Mn | - | -74.60% |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | -74.60% |
| Mar 31, 2026 | -82.54% |
| Dec 31, 2025 | -84.16% |
| Sep 30, 2025 | -71.53% |
| Jun 30, 2025 | -75.68% |
| Mar 31, 2025 | -65.22% |
| Dec 31, 2024 | -52.38% |
| Sep 30, 2024 | -49.02% |
| Jun 30, 2024 | -48.46% |
| Mar 31, 2024 | -43.03% |
API Access
Mereo BioPharma Return on Assets [ROA] API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=return-on-assets-%5Broa%5D&ticker=MREO&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "return-on-assets-[roa]", "ticker": "MREO", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=return-on-assets-%5Broa%5D&ticker=MREO&period=max&api_key=YOUR_API_KEY");
const data = await res.json();